Article Text

PDF
Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma
  1. Marcus Mottershead1,
  2. Emmanuel Karteris2,
  3. Jill Y Barclay2,
  4. Saira Suortamo1,
  5. Mark Newbold1,
  6. Harpal Randeva2,
  7. Chuka U Nwokolo1
  1. 1Departments of Gastroenterology and Pathology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
  2. 2Biomedical Research Institute, University of Warwick, Warwick, UK
  1. Correspondence to:
    Professor C U Nwokolo
    Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK; chukanwokolo{at}compuserve.com

Abstract

Background: Ghrelin is an orexigenic gut peptide produced predominantly by the stomach. Gastric mucosal ghrelin production could be compromised by an infiltrating adenocarcinoma.

Aims: To assess the expression of ghrelin mRNA and peptide in oesophagogastric adenocarcinomas and adjacent non-neoplastic mucosa.

Methods: 10 gastric and 22 oesophageal adenocarcinoma archival samples were randomly selected from a database. The presence of ghrelin-positive cells was assessed in cancer and corresponding non-neoplastic mucosa by immunohistochemistry. Quantitative reverse transcriptase polymerase chain reaction (PCR) for ghrelin mRNA was also performed on 24 gastric and 8 oesophageal adenocarcinoma specimens and adjacent non-neoplastic mucosa.

Results: Immunohistochemistry and reverse transcriptase PCR confirm a negligible expression of ghrelin in adenocarcinoma specimens. By contrast, non-neoplastic gastric mucosa was rich in ghrelin-positive cells and ghrelin mRNA. The number (median and range) of ghrelin-positive cells per 2 mm section of non-neoplastic mucosa was 73 (45–215) in the corpus; this was significantly higher than in cardia mucosa (9 (0–64), p<0.001) and antral mucosa (5 (0–14), p<0.001).

Conclusions: Gastric and oesophageal adenocarcinomas have no ghrelin-producing cells. The highest level of ghrelin expression was noted in the non-neoplastic mucosa of the gastric corpus. Disruption of the gastric ghrelin-producing mechanism may occur during oesophagogastric malignancy.

  • PCR, polymerase chain reaction

Statistics from Altmetric.com

Footnotes

  • Published Online First 2 June 2006

  • Competing interests: None.

  • Ethical considerations: The Coventry Research Ethics Committee gave ethical approval. Patients gave written informed consent for samples collected peri-operatively.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.